Brief: Peijia Medical Says Prelim H1 Revenue Of About RMB 415.0–435.0 MLN
07/08/2026 14:45
BRIEF-Peijia Medical Says Prelim H1 Revenue Of About RMB 415.0–435.0 MLN Aug 7 (Reuters) - Peijia Medical Ltd 9996.HK:
PRELIM H1 2026 REVENUE ABOUT RMB 415.0–435.0 MILLION, UP FROM RMB 353.4 MILLION
Further company coverage: 9996.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Peijia Medical
See all newsBrief: Peijia Medical Says Sequent Please Cis Balloon Dilatation Catheter Receives NMPA Registration Approval
Brief: Peijia Medical Receives NMPA Approval For Geminione Transcatheter Edge-To-Edge Repair System
China's Peijia Medical H1 revenue jumps on transcatheter valve therapeutics growth
Brief: Peijia Medical Says Prelim H1 Revenue Of About RMB 415.0–435.0 MLN
Brief: Peijia Medical Says Achieva Medical Enters Exclusive Distribution Agreement With B. Braun Medical